Assess Tolerability, Safety and Pharmacology of hGH-ViaDerm™ System in Adults With GH-Deficiency
Study Title
- A Multi-Dose Study to Assess Tolerability, Safety and Pharmacology of hGH-ViaDermג„¢ System in Adults With GH-Deficiency
Teva Identifier
- GH-VD-102
ClinicalTrials.gov Identifier
- NCT00455260
Study Status
- Completed
Trial Condition(s)
- Growth Hormone Deficiency
Interventions
- Drug: hGH-ViaDermג„¢ System (hGH or somatropin) | Device: hGH-ViaDermג„¢ System
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 20 Years to 60 Years
Trial Duration
- 04/01/2007 - 01/00/1900
Phase
- Phase 1
Study Type
Interventional
